Novo Nordisk (NVO) is expected to beat estimates when it reports its first-quarter 2025 results before the opening bell on May 7, 2025. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is pegged at 11.33billion,whilethesameforearningsispinnedat91centspershare.(SeetheZacks EarningsCalendartostayaheadofmarket−makingnews.)Inthepast30days,theZacksConsensusEstimateforNovoNordisk’s2025earningspershare(EPS)declinedfrom3.88 to $3.81. Durin ...